Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:09 PM
Ignite Modification Date:
2025-12-24 @ 10:09 PM
NCT ID:
NCT00002135
Eligibility Criteria:
Inclusion Criteria
Patients must have:
* AIDS.
* Stable CMV retinitis.
* Treatment with IV ganciclovir or IV foscarnet for at least 18 of the past 21 days.
* No permanent central IV catheter at present.
* Had a permanent central IV catheter removed two or more times within the past 6 months due to catheter infection or thrombosis.
* Consent of guardian if less than legal age of consent.
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms or conditions are excluded:
* Require continuation of concomitant medications precluded by this protocol.
Concurrent Medication:
Excluded:
* Intravitreal anti-CMV treatment.
* Any other concomitant medications precluded by the protocol.
Patients with the following prior condition are excluded:
History of hypersensitivity to acyclovir or ganciclovir.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
13 Years
Study:
NCT00002135
Study Brief:
Protocol Section:
NCT00002135